GAMMA Investing’s Nanobiotix NBTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$37.1K Buy
985
+157
+19% +$5.84K ﹤0.01% 2499
2026
Q1
$25.6K Buy
828
+599
+262% +$15.8K ﹤0.01% 2589
2025
Q4
$5.29K Buy
+229
New +$5K ﹤0.01% 3250
2025
Q1
Sell
-154
Closed -$442 3855
2024
Q4
$442 Sell
154
-2,703
-95% -$10.8K ﹤0.01% 3591
2024
Q3
$16.4K Buy
2,857
+827
+41% +$4.31K ﹤0.01% 2218
2024
Q2
$10.2K Buy
2,030
+880
+77% +$5.3K ﹤0.01% 2244
2024
Q1
$7.47K Buy
1,150
+975
+557% +$6.89K ﹤0.01% 2210
2023
Q4
$1.33K Buy
+175
New +$1.11K ﹤0.01% 2708

Other funds holding NBTX

GAMMA Investing's NBTX Position: Q2 2026 in Review

GAMMA Investing increased its Nanobiotix (NBTX) stake by 19% in Q2 2026, buying an estimated $5.84K and bringing the position to 985 shares worth $37.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2499.

GAMMA Investing first reported a position in NBTX in Q4 2023 and has held it in 8 quarters since. 11 funds tracked by Wall St. Rank hold NBTX as of Q2 2026.

  • GAMMA Investing held 985 shares of Nanobiotix worth $37.1K as of Q2 2026.
  • GAMMA Investing bought 157 Nanobiotix shares in Q2 2026, an estimated $5.84K.
  • Nanobiotix made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2499 holding.
  • GAMMA Investing first reported a position in Nanobiotix in Q4 2023 and has held it in 8 quarters since.
  • 11 funds tracked by Wall St. Rank held Nanobiotix as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.